| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Envelope protein p54,Ba71V-126,E183L |
| Clonality | |
| Conjugate | |
| Form | Liquid |
| Host | |
| Immunogen | Recombinant Envelope protein p54 protein (54-183AA) |
| Isotype | |
| Product Type | |
| Reactivity | |
| Source | This product is a monoclonal antibody produced from mouse hybridoma cells. |
| Storage | |
| Target | |
| UniProt # |
Overview
This is a monoclonal anti-Envelope protein p54 antibody raised in Mouse, with confirmed utility in ELISA. It is designed to detect Envelope protein p54 protein in African swine fever virus and supports researchers working in others contexts.
Key elements and design rationale
- Immunogen: Recombinant Envelope protein p54 protein (54-183AA) — determines the epitope region; confirm compatibility with sample preparation and expected post-translational modifications.
- Host species (Mouse): Requires anti-mouse-IgG secondary reagents for indirect detection.
- Monoclonal format: Single-epitope binding provides high specificity and lot-to-lot reproducibility. Confirm epitope accessibility under your assay conditions.
- Isotype (IgG3): Matched secondary antibodies and isotype controls required. Compatible with standard Protein A/G purification workflows.
- Purification (Protein G purification): Enriches for specific immunoglobulin classes; reduces non-specific background vs. crude antisera.
Biological background
Envelope protein p54 (also referred to as Envelope protein p54,Ba71V-126,E183L) is a protein target studied in African swine fever virus systems. Expression, subcellular localization, and post-translational modifications vary across cell types and disease states — factors critical to antibody-based detection design. Consult UniProt, NCBI Gene, and primary literature for current annotation of Envelope protein p54 biology in others.
Common research applications
- ELISA: Quantification of soluble target in biological fluids or culture supernatants. Ensure samples are within the linear detection range.
Notes for experimental interpretation
- Isotype controls: Use an isotype-matched (IgG3 from Mouse) control at equivalent concentration to assess non-specific background.
- Cross-reactivity: Confirm the clone does not cross-react with related family members under your assay conditions.
- Matrix effects: Sample matrix can affect performance; pilot dilution linearity and spike-recovery experiments are advised for quantitative studies.
- Species reactivity: Confirmed for African swine fever virus. Extrapolation to untested species requires empirical validation.
This product is a monoclonal antibody produced from mouse hybridoma cells.
Envelope protein p54 is a protein target in African swine fever virus biology. This monoclonal antibody raised in Mouse is designed to detect Envelope protein p54 in ELISA applications, with IgG3 isotype.
Reported reactive against African swine fever virus. Immunogen derived from African swine fever virus. Cross-reactivity with other species should not be assumed without documented data or empirical testing.
Reported for ELISA. Each format requires independent dilution optimization and appropriate controls. Unlisted applications require empirical testing.
This non-conjugated IgG3 antibody requires a compatible secondary. Select anti-mouse IgG secondary conjugated to your preferred reporter (HRP, AP, fluorophore, or biotin), matched to IgG3.
(1) Isotype control — IgG3 from Mouse at matching concentration; (2) Positive control — known Envelope protein p54-expressing cell/tissue; (3) Negative control — knockdown/knockout sample for specificity; (4) Dilution linearity — verify proportional signal decrease in your matrix.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
